EVH
Evolent Health Inc - A
2 of the 83 super-investors we track hold EVH, worth a combined $33M per their latest 13F filings. The largest position: Glenn Welling at 9.2% of their portfolio. No cohort buying or selling was filed on the name this quarter. Conviction score: 34 of 100 (how strongly the cohort backs it) — ranked #226 of 742 stocks. Conviction easing: 1 fewer super-investor hold it than in 2026Q1.
Why super-investors own EVH
EVH is held by 2 super-investors in our cohort, with a combined position value of $33M. The highest-conviction owner is Glenn Welling at 9.2% of their portfolio. Cohort ownership has shrunk from 3 to 2 over the last four quarters — net interest is fading.
AI-synthesized from 13F filings. Not investment advice.
Cohort owners over time
2016Q3 → 2026Q2How many of the cohort members held this stock each quarter.
Owners (2) · click any column to sort
| #↑ | Manager | % Port. | History | Value | Shares |
|---|---|---|---|---|---|
| 1 | Glenn Welling | 9.2% | 24q | $30M | 5,563,912 |
| 2 | Joel Greenblatt | <0.1% | 37q | $3M | 488,814 |
Owners of EVH also hold
Congress is trading EVH
Congress tracker →- Greg Gianfortesold$50,001 - $100,000 · 2020-05-11
- Greg Gianfortebought$100,001 - $250,000 · 2019-10-11 · late
- Greg Gianfortesold$50,001 - $100,000 · 2019-09-10
- Greg Gianfortebought$15,001 - $50,000 · 2018-12-20
- Greg Gianfortebought$50,001 - $100,000 · 2018-06-07
STOCK Act periodic transaction reports; amounts are disclosed ranges. Who files late →
Long US equity 13F-HR filings only. CUSIP 30050B101. Not investment advice.